Slow and Steady Will Not Win the Race: Trade Negotiations, IP Protections and Canada’s Pharmaceutical Industry
The rapid and vast growth of the biopharmaceutical industry necessitates, for Canada, increased intellectual property protection in order to keep up with competitors in the pharmaceutical market.
Read Laura's full article here.
About the Author
The mission of the Wilson Center's Canada Institute is to raise the level of knowledge of Canada in the United States, particularly within the Washington, DC policy community. Research projects, initiatives, podcasts, and publications cover contemporary Canada, US-Canadian relations, North American political economy, and Canada's global role as it intersects with US national interests. Read more